rs41311343

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_032119.4(ADGRV1):​c.10577T>C​(p.Met3526Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0292 in 1,613,534 control chromosomes in the GnomAD database, including 845 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.023 ( 63 hom., cov: 32)
Exomes 𝑓: 0.030 ( 782 hom. )

Consequence

ADGRV1
NM_032119.4 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11O:1

Conservation

PhyloP100: -2.04

Publications

13 publications found
Variant links:
Genes affected
ADGRV1 (HGNC:17416): (adhesion G protein-coupled receptor V1) This gene encodes a member of the G-protein coupled receptor superfamily. The encoded protein contains a 7-transmembrane receptor domain, binds calcium and is expressed in the central nervous system. Mutations in this gene are associated with Usher syndrome 2 and familial febrile seizures. Several alternatively spliced transcripts have been described. [provided by RefSeq, Jul 2008]
ADGRV1 Gene-Disease associations (from GenCC):
  • Usher syndrome type 2
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 2C
    Inheritance: AR Classification: STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • febrile seizures, familial, 4
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0023483634).
BP6
Variant 5-90745073-T-C is Benign according to our data. Variant chr5-90745073-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 46249.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0227 (3451/152292) while in subpopulation NFE AF = 0.0352 (2395/68002). AF 95% confidence interval is 0.034. There are 63 homozygotes in GnomAd4. There are 1656 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 63 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADGRV1NM_032119.4 linkc.10577T>C p.Met3526Thr missense_variant Exon 51 of 90 ENST00000405460.9 NP_115495.3 Q8WXG9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADGRV1ENST00000405460.9 linkc.10577T>C p.Met3526Thr missense_variant Exon 51 of 90 1 NM_032119.4 ENSP00000384582.2 Q8WXG9-1

Frequencies

GnomAD3 genomes
AF:
0.0227
AC:
3451
AN:
152174
Hom.:
63
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00579
Gnomad AMI
AF:
0.0757
Gnomad AMR
AF:
0.0142
Gnomad ASJ
AF:
0.0121
Gnomad EAS
AF:
0.00347
Gnomad SAS
AF:
0.0145
Gnomad FIN
AF:
0.0338
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0352
Gnomad OTH
AF:
0.0191
GnomAD2 exomes
AF:
0.0231
AC:
5748
AN:
249126
AF XY:
0.0232
show subpopulations
Gnomad AFR exome
AF:
0.00484
Gnomad AMR exome
AF:
0.0111
Gnomad ASJ exome
AF:
0.0132
Gnomad EAS exome
AF:
0.00295
Gnomad FIN exome
AF:
0.0372
Gnomad NFE exome
AF:
0.0330
Gnomad OTH exome
AF:
0.0222
GnomAD4 exome
AF:
0.0299
AC:
43629
AN:
1461242
Hom.:
782
Cov.:
31
AF XY:
0.0294
AC XY:
21344
AN XY:
726924
show subpopulations
African (AFR)
AF:
0.00475
AC:
159
AN:
33476
American (AMR)
AF:
0.0114
AC:
510
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0123
AC:
321
AN:
26130
East Asian (EAS)
AF:
0.00224
AC:
89
AN:
39668
South Asian (SAS)
AF:
0.0157
AC:
1356
AN:
86244
European-Finnish (FIN)
AF:
0.0359
AC:
1914
AN:
53388
Middle Eastern (MID)
AF:
0.00486
AC:
28
AN:
5766
European-Non Finnish (NFE)
AF:
0.0340
AC:
37810
AN:
1111484
Other (OTH)
AF:
0.0239
AC:
1442
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
1966
3932
5897
7863
9829
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1350
2700
4050
5400
6750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0227
AC:
3451
AN:
152292
Hom.:
63
Cov.:
32
AF XY:
0.0222
AC XY:
1656
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.00577
AC:
240
AN:
41582
American (AMR)
AF:
0.0142
AC:
217
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0121
AC:
42
AN:
3470
East Asian (EAS)
AF:
0.00347
AC:
18
AN:
5180
South Asian (SAS)
AF:
0.0145
AC:
70
AN:
4820
European-Finnish (FIN)
AF:
0.0338
AC:
359
AN:
10618
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0352
AC:
2395
AN:
68002
Other (OTH)
AF:
0.0189
AC:
40
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
174
348
523
697
871
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0278
Hom.:
145
Bravo
AF:
0.0197
TwinsUK
AF:
0.0305
AC:
113
ALSPAC
AF:
0.0376
AC:
145
ESP6500AA
AF:
0.00476
AC:
18
ESP6500EA
AF:
0.0304
AC:
250
ExAC
AF:
0.0232
AC:
2799
Asia WGS
AF:
0.0110
AC:
37
AN:
3478
EpiCase
AF:
0.0297
EpiControl
AF:
0.0277

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Apr 10, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 14, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Nov 07, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:4Other:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
NEI Ophthalmic Genomics Laboratory, National Institutes of Health
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Jan 26, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 03, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Usher syndrome type 2C Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.64
CADD
Benign
0.046
DANN
Benign
0.34
DEOGEN2
Benign
0.063
T;T
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.9
FATHMM_MKL
Benign
0.019
N
LIST_S2
Benign
0.25
.;T
MetaRNN
Benign
0.0023
T;T
MetaSVM
Benign
-1.0
T
PhyloP100
-2.0
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-0.090
.;N
REVEL
Benign
0.045
Sift
Benign
0.57
.;T
Sift4G
Benign
0.57
.;T
Polyphen
0.0050
B;B
Vest4
0.028
MPC
0.053
ClinPred
0.0018
T
GERP RS
-11
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.048
gMVP
0.30
Mutation Taster
=73/27
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41311343; hg19: chr5-90040890; COSMIC: COSV67991170; COSMIC: COSV67991170; API